Opeyemi Iwaloye

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

Emergency Department

Molecular Dynamics

Lymph Node Metastasis

Top Venues

Journal of biomolecular structure & dynamics

In silico pharmacology

Molecular diversity

Pathophysiology : the official journal of the International Society for Pathophysiology

This page only lists publications with an associated author ORCID identifier.

Publications

Oluwatoyin Folake Olukunle, Christopher Busayo Olowosoke, Aqsa Khalid, Grace Ayomide Oke, Victor Omoboyede, Haruna Isiyaku Umar, Ochapa Ibrahim, Covenant Femi Adeboboye, Opeyemi Iwaloye, Femi Olawale, Ayodeji Adeola Adedeji, Taye Bello, Hafsat Olateju Alabere, Prosper Obed Chukwuemeka
Identification of a 1, 8-naphthyridine-containing compound endowed with the inhibition of p53-MDM2/X interaction signaling: a computational perspective. Molecular diversity (2023)
Kolawole Olofinsan, Femi Olawale, Kayode Karigidi, Sergey Shityakov, Opeyemi Iwaloye
Probing the bioactive compounds of Kigelia africana as novel inhibitors of TNF-α converting enzyme using HPLC/GCMS analysis, FTIR and molecular modelling. Journal of biomolecular structure & dynamics (2023)
Babatomiwa Kikiowo, Iqrar Ahmad Ansari, Adebowale A Alade, Taiwo T Ijatuyi, Opeyemi Iwaloye, Harun M Patel
Molecular dynamics simulation and pharmacokinetics studies of ombuin and quercetin against human pancreatic α-amylase. Journal of biomolecular structure & dynamics (2022)
Babatomiwa Kikiowo, Iqrar Ahmad Ansari, Adebowale A Alade, Taiwo T Ijatuyi, Opeyemi Iwaloye, Harun M Patel
Molecular dynamics simulation and pharmacokinetics studies of ombuin and quercetin against human pancreatic α-amylase. Journal of biomolecular structure & dynamics (2022)
Olusola Olalekan Elekofehinti, Opeyemi Iwaloye, Femi Olawale, Esther Opeyemi Ariyo
Saponins in Cancer Treatment: Current Progress and Future Prospects. Pathophysiology : the official journal of the International Society for Pathophysiology 28 (2) (2021)
Olusola Olalekan Elekofehinti, Opeyemi Iwaloye, Femi Olawale, Prosper Obed Chukwuemeka, Ibukun Mary Folorunso
Newly designed compounds from scaffolds of known actives as inhibitors of survivin: computational analysis from the perspective of fragment-based drug design. In silico pharmacology 9 (1) (2021)
Prosper Obed Chukwuemeka, Haruna Isiyaku Umar, Opeyemi Iwaloye, Oluwaseyi Matthew Oretade, Christopher Busayo Olowosoke, Oyeyemi Janet Oretade, Michael Omoniyi Elabiyi
Predictive hybrid paradigm for cytotoxic activity of 1,3,4-thiadiazole derivatives as CDK6 inhibitors against human (MCF-7) breast cancer cell line and its structural modifications: rational for novel cancer therapeutics. Journal of biomolecular structure & dynamics (2021)
Prosper Obed Chukwuemeka, Haruna Isiyaku Umar, Opeyemi Iwaloye, Oluwaseyi Matthew Oretade, Christopher Busayo Olowosoke, Michael Omoniyi Elabiyi, Festus Omotere Igbe, Oyeyemi Janet Oretade, Joy Oseme Eigbe, Funmilayo Janet Adeojo
Targeting p53-MDM2 interactions to identify small molecule inhibitors for cancer therapy: beyond "Failure to rescue". Journal of biomolecular structure & dynamics (2021)
Opeyemi Iwaloye, Olusola Olalekan Elekofehinti, Emmanuel Ayo Oluwarotimi, Babatom Iwa Kikiowo, Toyin Mary Fadipe
Insight into glycogen synthase kinase-3β inhibitory activity of phyto-constituents from Melissa officinalis: in silico studies. In silico pharmacology 8 (1) (2020)